Frederiksstaden Pharma ApS: Financial statements 2023
CVR: 25630483
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -79,848 and a net result of DKK -82,296 compared with DKK 3,759 the year before. Equity in the 2023 report amounted to DKK 148,685. The solvency ratio was 45.3%.
- Gross Profit
- DKK -79,848
- Profit/Loss
- DKK -82,296
- Equity
- DKK 148,685
- Total Assets
- DKK 328,485
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -80 t. | -82 t. | 149 t. | 0 |
| 2022 | - | 13 t. | 4 t. | 231 t. | 0 |
| 2021 | - | -666 t. | -1.4 mio. | 227 t. | 3 |
| 2020 | - | 2 mio. | -1.8 mio. | 1.6 mio. | 7 |
| 2019 | - | 1.4 mio. | -3.3 mio. | -2.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Frederiksstaden Pharma ApS has published its annual report for 2022. Gross profit came to DKK 13,098, and the net result was DKK 3,759.
About Frederiksstaden Pharma ApS
Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.